Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21). (Q47385263)

15 January 2018

title

Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21). (English)

1 reference

15 January 2018

0 references

1 reference

Haytham Khoury

1

1 reference

15 January 2018

Bakul I Dalal

2

1 reference

15 January 2018

Stephen H Nantel

3

1 reference

15 January 2018

Douglas E Horsman

4

1 reference

15 January 2018

Julye C Lavoie

5

1 reference

15 January 2018

John D Shepherd

6

1 reference

15 January 2018

Donna E Hogge

7

1 reference

15 January 2018

Cynthia L Toze

8

1 reference

15 January 2018

Kevin W Song

9

1 reference

15 January 2018

Donna L Forrest

10

1 reference

15 January 2018

Heather J Sutherland

11

1 reference

15 January 2018

Thomas J Nevill

12

1 reference

15 January 2018

publication date

1 October 2004

1 reference

15 January 2018

published in

Modern Pathology

1 reference

15 January 2018

volume

17

1 reference

15 January 2018

issue

10

1 reference

15 January 2018

page(s)

1211-1216

1 reference

15 January 2018

ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

7 January 2021

Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

7 January 2021

Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

7 January 2021

Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

7 January 2021

Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

7 January 2021

Acute myeloblastic leukemia (ANLL-M2) with t(8;21)(q22;q22) variant expressing lymphoid but not myeloid surface antigens with a high number of G-CSF receptors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

7 January 2021

Cytogenetically cryptic AML1-ETO and CBFbeta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800168

7 January 2021

10.1038/MODPATHOL.3800168

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018